Case Law | Business Litigation | Society

California jury sides with family of woman who died from mesothelioma

In a major legal blow, a California jury has ordered Johnson & Johnson (J&J) to pay $966 million in damages to the family of a woman who died from mesothelioma, a rare and aggressive cancer linked to asbestos exposure.

The verdict, delivered this week in a state court in Oakland, is one of the largest awards to date in J&J’s long-running talc litigation saga and adds to the mounting financial and reputational pressure facing the pharmaceutical and consumer goods giant.

The Case: A Fatal Link to Talc

The lawsuit was brought by the family of a California woman who used J&J’s talcum powder products for decades before being diagnosed with mesothelioma — a cancer most commonly caused by inhaling asbestos fibers. The family alleged that contaminated talc in Johnson’s Baby Powder was the cause of her illness and subsequent death.

Jurors were persuaded by expert testimony and internal documents that suggested J&J’s talc products were tainted with asbestos, and that the company failed to adequately warn consumers.

“This verdict sends a clear message that companies will be held accountable when they prioritize profits over people,” said the family’s attorney in a statement.

J&J’s Response

Johnson & Johnson said it strongly disagrees with the verdict and plans to appeal.

“We deeply sympathize with anyone suffering from cancer, but decades of independent scientific evaluations have confirmed that our talc is safe, does not contain asbestos, and does not cause cancer,” the company said in a statement.

J&J has consistently denied that its talc products contain asbestos or pose a health risk. However, it announced in 2023 that it would discontinue global sales of talc-based baby powder and transition to a cornstarch-based formula.

Legal and Financial Impact

The nearly $1 billion judgment adds to a growing list of talc-related liabilities for J&J. The company faces tens of thousands of lawsuits across the U.S., many of which have been consolidated in federal multidistrict litigation (MDL).

J&J has twice attempted to resolve these claims through a controversial legal maneuver known as the “Texas Two-Step” bankruptcy strategy, in which it spun off a subsidiary to absorb liability and then filed for bankruptcy protection. Courts have rejected both attempts, most recently in 2023, stating the company was not in financial distress.

With this latest verdict, plaintiffs’ lawyers are expected to intensify litigation efforts, especially in cases involving mesothelioma or ovarian cancer — the two primary diseases cited in talc suits.

A Precedent-Setting Case?

Legal analysts say the size of the award — which includes both compensatory and punitive damages — reflects growing jury frustration with corporate transparency and risk disclosure.

“This is a signal case. It tells us that juries are willing to hit companies hard if they believe there’s been deception or denial of harm,” said one mass tort attorney.

If upheld on appeal, the ruling could reshape J&J’s litigation strategy, force further settlement negotiations, or even lead to renewed bankruptcy protection efforts under a different structure.

Conclusion: A Verdict with Industry-Wide Ripples

The $966 million judgment marks a turning point in the decade-long talc litigation battle and reinforces the legal risks companies face when legacy products collide with modern liability standards.

As lawsuits continue to move forward in multiple jurisdictions, Johnson & Johnson — and other manufacturers facing similar claims — will be watching closely. The stakes are no longer just financial; they now cut to the heart of corporate trust and public accountability.